1
|
Scavone M, Ghali C, Calogiuri M, Sala M, Bossi E, Mencarini T, Bozzi S, Clerici B, Birocchi S, Fioretti A, Bono V, Maugeri N, Marchetti G, Cattaneo M, Podda GM. Impairment of platelet function in both mild and severe COVID-19 patients. Br J Haematol 2023; 203:656-667. [PMID: 37615207 DOI: 10.1111/bjh.19062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 08/07/2023] [Accepted: 08/12/2023] [Indexed: 08/25/2023]
Abstract
Abnormalities of platelet function were reported in patients with severe COVID-19 (severe-C), but few data are available in patients with mild COVID-19 (mild-C) and after COVID-19 recovery. The aim of this study was to investigate platelet parameters in mild-C patients (n = 51), with no evidence of pneumonia, and severe-C patients (n = 49), during the acute phase and after recovery, compared to 43 healthy controls. Both mild-C and severe-C patients displayed increased circulating activated platelets, low δ-granule content (ADP, serotonin), impaired platelet activation by collagen (light transmission aggregometry) and impaired platelet thrombus formation on collagen-coated surfaces under controlled flow conditions (300/s shear rate). The observed abnormalities were more marked in severe-C patients than in mild-C patients. Overall, 61% (30/49) of mild-C and 73% (33/45) of severe-C patients displayed at least one abnormal platelet parameter. In a subgroup of just 13 patients who showed no persisting signs/symptoms of COVID-19 and were re-evaluated at least 1 month after recovery, 11 of the 13 subjects exhibited normalization of platelet parameters. In conclusion, mild abnormalities of platelet parameters were present not only in severe-C but also, albeit to a lesser extent, in mild-C patients during the acute phase of COVID-19 and normalized in most tested patients after clinical recovery.
Collapse
Affiliation(s)
- Mariangela Scavone
- Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
| | - Claudia Ghali
- Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
| | - Mariagrazia Calogiuri
- Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
| | - Matteo Sala
- ASST Santi Paolo e Carlo, Department of Health Sciences, Clinic of Infectious Diseases, San Paolo Hospital, University of Milan, Italy
| | - Elena Bossi
- Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
| | - Tatiana Mencarini
- Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy
| | - Silvia Bozzi
- Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy
| | - Bianca Clerici
- Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
| | - Simone Birocchi
- Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
| | - Antonella Fioretti
- Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
| | - Valeria Bono
- ASST Santi Paolo e Carlo, Department of Health Sciences, Clinic of Infectious Diseases, San Paolo Hospital, University of Milan, Italy
| | - Norma Maugeri
- IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Giulia Marchetti
- ASST Santi Paolo e Carlo, Department of Health Sciences, Clinic of Infectious Diseases, San Paolo Hospital, University of Milan, Italy
| | - Marco Cattaneo
- Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
| | - Gian Marco Podda
- Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
| |
Collapse
|
2
|
Varisco B, Bai F, De Benedittis S, Tavelli A, Cozzi-Lepri A, Sala M, Miraglia FG, Santoro MM, Ceccherini-Silberstein F, Shimoni Y, Ravid S, Kozlovski T, König F, Pfeifer N, Shamsara E, Parczewski M, Monforte AD, Incardona F, Mommo C, Marchetti G. EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations. BMC Infect Dis 2023; 23:684. [PMID: 37833640 PMCID: PMC10576381 DOI: 10.1186/s12879-023-08595-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Accepted: 09/11/2023] [Indexed: 10/15/2023] Open
Abstract
BACKGROUND Post-COVID-19 condition refers to persistent or new onset symptoms occurring three months after acute COVID-19, which are unrelated to alternative diagnoses. Symptoms include fatigue, breathlessness, palpitations, pain, concentration difficulties ("brain fog"), sleep disorders, and anxiety/depression. The prevalence of post-COVID-19 condition ranges widely across studies, affecting 10-20% of patients and reaching 50-60% in certain cohorts, while the associated risk factors remain poorly understood. METHODS This multicentre cohort study, both retrospective and prospective, aims to assess the incidence and risk factors of post-COVID-19 condition in a cohort of recovered patients. Secondary objectives include evaluating the association between circulating SARS-CoV-2 variants and the risk of post-COVID-19 condition, as well as assessing long-term residual organ damage (lung, heart, central nervous system, peripheral nervous system) in relation to patient characteristics and virology (variant and viral load during the acute phase). Participants will include hospitalised and outpatient COVID-19 patients diagnosed between 01/03/2020 and 01/02/2025 from 8 participating centres. A control group will consist of hospitalised patients with respiratory infections other than COVID-19 during the same period. Patients will be followed up at the post-COVID-19 clinic of each centre at 2-3, 6-9, and 12-15 months after clinical recovery. Routine blood exams will be conducted, and patients will complete questionnaires to assess persisting symptoms, fatigue, dyspnoea, quality of life, disability, anxiety and depression, and post-traumatic stress disorders. DISCUSSION This study aims to understand post-COVID-19 syndrome's incidence and predictors by comparing pandemic waves, utilising retrospective and prospective data. Gender association, especially the potential higher prevalence in females, will be investigated. Symptom tracking via questionnaires and scales will monitor duration and evolution. Questionnaires will also collect data on vaccination, reinfections, and new health issues. Biological samples will enable future studies on post-COVID-19 sequelae mechanisms, including inflammation, immune dysregulation, and viral reservoirs. TRIAL REGISTRATION This study has been registered with ClinicalTrials.gov under the identifier NCT05531773.
Collapse
Affiliation(s)
- Benedetta Varisco
- Department of Health Sciences, Clinic of Infectious Diseases, University of Milan, ASST Santi Paolo E Carlo, Via A Di Rudinì 8, 20142, Milan, Italy
| | - Francesca Bai
- Department of Health Sciences, Clinic of Infectious Diseases, University of Milan, ASST Santi Paolo E Carlo, Via A Di Rudinì 8, 20142, Milan, Italy
| | | | | | - Alessandro Cozzi-Lepri
- Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK
| | - Matteo Sala
- Department of Health Sciences, Clinic of Infectious Diseases, University of Milan, ASST Santi Paolo E Carlo, Via A Di Rudinì 8, 20142, Milan, Italy
| | | | | | | | - Yishai Shimoni
- Healthcare Informatics, IBM Research-Haifa, Mount Carmel Haifa, Israel
| | - Sivan Ravid
- Healthcare Informatics, IBM Research-Haifa, Mount Carmel Haifa, Israel
| | - Tal Kozlovski
- Healthcare Informatics, IBM Research-Haifa, Mount Carmel Haifa, Israel
| | - Florian König
- Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany
| | - Nico Pfeifer
- Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany
| | - Elham Shamsara
- Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany
| | - Milosz Parczewski
- Department of Infectious Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Szczecin, Poland
| | | | | | | | - Giulia Marchetti
- Department of Health Sciences, Clinic of Infectious Diseases, University of Milan, ASST Santi Paolo E Carlo, Via A Di Rudinì 8, 20142, Milan, Italy.
| |
Collapse
|
3
|
d'Arminio Monforte A, Tavelli A, Rossotti R, Gagliardini R, Saracino A, Lo Caputo S, Sala M, Quiros-Roldan E, Mussini C, Girardi E, Cozzi-Lepri A, Antinori A, Puoti M. Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort. Liver Int 2023; 43:2130-2141. [PMID: 37649460 DOI: 10.1111/liv.15700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 07/21/2023] [Accepted: 08/07/2023] [Indexed: 09/01/2023]
Abstract
BACKGROUND AND AIMS Whether the HCV test-and-treat strategy impacted on the rate of new HCV infections among PLWH in Italy is unknown. METHODS Prospective study of PLWH in the ICONA network. At baseline, PLWH were tested for HCV-Ab; HCV-RNA (if HCV-Ab positive) and, if positive, treated with DAA. SVR12 indicated eradication. Seroconversions and re-infections were evaluated yearly in HCV-Ab neg and HCV-RNA neg at first screening. We estimated the following: HCV seroconversions, incidence of HCV reinfections, and access to DAA and SVR12 rates tighter with factors associated with each outcome. Data were analysed by Cox regression, Poisson regression and logistic regression models. RESULTS Sixteen thousand seven hundred and forty-three PLWH were included; 27.3% HCV-Ab positive; of these, 39.3% HCV-RNA positive. HCV seroconversion incidence: .48/100 PYFU (95% CI: .36-.65); re-infections incidence: 1.40/100 PYFU (95% CI: .91-2.04). The risk factor for HCV re-infection was young age: aIRR 1.85, 95% CI: 1.17-2.95) per 10 years younger. 86.4% of HCV viremic in follow-up started DAA. PWID vs. heterosexuals (aHR .75, 95% CI .62-.90), HIV-RNA >50 copies/mL (aHR .70, 95% CI .56-.87), HCV genotype other than G1, G2, G3, G4 or with multiple/missing HCV genotype and post-COVID-19 calendar periods were associated with lower DAA access. 922/965 (95.5%) PLWH achieved SVR12. We estimated 72% reduction of chance to achieve SVR12 in PLWH with a CD4 count <200/mm3 (vs. CD4 ≥200/mm3 aOR .18, 95% CI: .07-.46). 95.5% of DAA-treated individuals eradicated HCV, but they represent only 53.2% of HCV viremic PLWH and 66.4% of those in follow-up. HCV-RNA positivity by year decreased from 41.7% in 2017 to 11.7% in 2022. CONCLUSIONS The screening-and-treat campaign implemented in Italy, even if only partially effective, resulted in a dramatic drop in HCV circulation in our cohort.
Collapse
Affiliation(s)
| | | | - Roberto Rossotti
- Infectious Diseases Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - Roberta Gagliardini
- Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
| | - Annalisa Saracino
- Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, University of Bari, University Hospital Policlinico, Bari, Italy
| | - Sergio Lo Caputo
- Department of Clinical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - Matteo Sala
- Unit of Infectious and Tropical Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy
| | - Eugenia Quiros-Roldan
- Department of Clinical and Experimental Sciences, Unit of Infectious and Tropical Diseases, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
| | - Cristina Mussini
- AOU of Modena, Clinic of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy
| | - Enrico Girardi
- Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
| | - Alessandro Cozzi-Lepri
- Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK
| | - Andrea Antinori
- Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
| | - Massimo Puoti
- Infectious Diseases Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
- University of Milano-Bicocca, Milan, Italy
| |
Collapse
|
4
|
Barbanotti D, Tincati C, Tavelli A, Santoro A, Sala M, Bini T, De Bona A, d’Arminio Monforte A, Marchetti GC. HIV-Indicator Condition Guided Testing in a Hospital Setting. Life (Basel) 2023; 13:1014. [PMID: 37109543 PMCID: PMC10145962 DOI: 10.3390/life13041014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2023] [Revised: 04/06/2023] [Accepted: 04/12/2023] [Indexed: 04/29/2023] Open
Abstract
Late diagnosis is still a major issue in HIV infection management, leading to important consequences for both patients and community. In this perspective, HIV screening targeted on some clinical conditions (HIV indicator conditions-HIVICs) emerged as a useful strategy, also involving patients not considered at high behavioral risk. We organized an in-hospital HIVICs guided screening campaign named ICEBERG in Milan, Italy, between 2019 and 2021. Among the 520 subjects enrolled, mainly presenting with viral hepatitis or mononucleosis-like syndrome, 20 resulted HIV positive (3.8% prevalence). A significant proportion of them had multiple conditions and advanced immunosuppression, with 40% being AIDS-presenters. As adherence to the screening campaign was modest for non-ID specialists, educational interventions to raise clinicians' sensitivity are urgently needed. HIV-ICs guided testing was confirmed as a useful tool, but a combined approach with other screening strategies seems to be essential for early HIV diagnosis.
Collapse
Affiliation(s)
- Diletta Barbanotti
- Unit of Infectious Diseases, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20122 Milan, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
5
|
D'arminio Monforte A, Tavelli A, Sala M, Mondi A, Rusconi S, Antinori S, Puoti M, Celesia BM, Taramasso L, Saracino A, Antinori A, Cozzi-Lepri A. Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study. J Antimicrob Chemother 2023; 78:933-945. [PMID: 36775983 DOI: 10.1093/jac/dkad026] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Accepted: 01/18/2023] [Indexed: 02/14/2023] Open
Abstract
OBJECTIVES To compare the long-term risk of treatment failure of dolutegravir-based ART in men and women in a real-life setting. PATIENTS AND METHODS Persons living with HIV (PLWH) from the ICONA cohort were included if they had started dolutegravir in a two- or three-drug regimen as ART-naive or as virologically controlled ART-experienced. The primary endpoint was time to treatment failure (virological/clinical failure or dolutegravir discontinuation). Secondary endpoints were: time to dolutegravir discontinuation due to toxicity and to neuropsychiatric adverse events; and time to virological failure. Cox regression analyses focused on differences in outcomes by sex. RESULTS A total of 2304 PLWH (15% women) initiated dolutegravir-based therapy from ART-naive, and 1916 (19.8% women) while experienced. After a median follow-up of 2.2 (IQR: 0.9-3.9) years in ART-naive and 2.4 (IQR: 1.1-4.3) years in experienced, the 4-year cumulative probability of treatment failure was 33% (95% CI 30.5-35.1) and 20% (95% CI 17.8-22.3), respectively. In the multivariable analyses, in ART-naive the risk of treatment failure was higher for women, but not different after excluding women discontinuing dolutegravir for pregnancy concerns. We also observed a higher risk of discontinuation for toxicity in women (ART-naives: Adjusted Hazard Ratio (AHR): 1.56%; 95% CI: 1.03-2.37; ART-experienced: AHR: 1.53%; 95% CI: 1.01-2.32), although the absolute 4-year probability was low: 7.7% (95% CI 6.5-9.2) in ART-naive and 8.3% (95% CI 6.9-9.9) in experienced. CONCLUSIONS In our cohort of PLWH treated with dolutegravir-based regimens and followed up for up to 4 years, we observed a low risk of treatment failure and no evidence for a difference by sex, after excluding discontinuation due to pregnancy concerns. However, we observed a higher risk of dolutegravir discontinuation for toxicity in women.
Collapse
Affiliation(s)
- Antonella D'arminio Monforte
- Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, ASST Santi Paolo e Carlo, via A. di Rudinì 8, 20142, Milan, Italy
| | | | - Matteo Sala
- Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, ASST Santi Paolo e Carlo, via A. di Rudinì 8, 20142, Milan, Italy
| | - Annalisa Mondi
- Clinical and Research Infectious Diseases Department, National Institute of Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
| | - Stefano Rusconi
- Infectious Diseases Unit, Ospedale Civile di Legnano, ASST Ovest Milanese, and DIBIC Luigi Sacco, Università degli Studi di Milano, Legnano, Italy
| | - Spinello Antinori
- III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, and DIBIC Luigi Sacco, Università degli Studi di Milano, Milan, Italy
| | - Massimo Puoti
- Infectious Diseases Division, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | | | - Lucia Taramasso
- Clinic of Infectious Diseases, Policlinico San Martino Hospital IRCCS, Genova, Italy
| | - Annalisa Saracino
- Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy
| | - Andrea Antinori
- Clinical and Research Infectious Diseases Department, National Institute of Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
| | - Alessandro Cozzi-Lepri
- Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK
| |
Collapse
|
6
|
Sforza M, Sala M, Leitner C, Casoni F, Zucconi M, Galbiati A, Ferini Strambi L, Castronovo V. Affective states in predicting and mediating Cognitive-Behavioral Therapy for Insomnia. Sleep Med 2022. [DOI: 10.1016/j.sleep.2022.05.298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
7
|
Barceló-Vidal J, Echeverría-Esnal D, Carballo N, De Antonio-Cuscó M, Fernández-Sala X, Navarrete-Rouco ME, Colominas-González E, Luque S, Fuster-Esteva M, Domingo L, Sala M, Duran X, Grau S, Ferrández O. Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic. Front Pharmacol 2022; 13:993158. [PMID: 36506516 PMCID: PMC9730804 DOI: 10.3389/fphar.2022.993158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Accepted: 10/18/2022] [Indexed: 11/25/2022] Open
Abstract
Introduction: Drug-related problems (DRP) are events or circumstances in which drug therapy does or could interfere with desired health outcomes. In December 2019, a new coronavirus, SARS-CoV-2, appeared. Little knowledge about this type of infection resulted in the administration of various drugs with limited use in other pathologies. Evidence about DRP in patients with COVID-19 is lacking. Objective: The aim of the present study is to describe identified cases of DRP and those drugs involved in the first wave of patients with COVID-19, and evaluate associated risk factors. Material and methods: Observational, retrospective study performed in a tertiary university hospital between 14th March 2020 and 31 May 2020 (corresponding to the first COVID-19 wave). We recruited patients admitted during the study period. Exclusion criteria included age < 18 years; admission to critically ill units; and care received either in the emergency room, at-home hospitalization or a healthcare center. Results: A total of 817 patients were included. The mean age was 62.5 years (SD 16.4) (range 18-97), and 453 (55.4%) were male. A total of 516 DRP were detected. Among the patients, 271 (33.2%) presented at least one DRP. The mean DRP per patient with an identified case was 1.9. The prevailing DRPs among those observed were: incorrect dosage (over or underdosage) in 145 patients (28.2%); wrong drug combination in 131 (25.5%); prescriptions not in adherence to the then COVID-19 treatment protocol in 73 (14.1%); prescription errors due to the wrong use of the computerized physician order entry in 47 (9.2%); and incorrect dosage due to renal function in 36 (7%). The logistic regression analysis showed that patients who received only prescriptions of antibacterials for systemic use (J01 ATC group) faced a higher likelihood of experiencing a DRP (OR 2.408 (1.071-5.411), p = 0.033). Conclusion: We identified several factors associated with an increased risk of DRPs, similar to those reported in other pre-pandemic studies, including a prolonged length of stay, higher number of prescribed drugs and antimicrobial administration. The relevance of pharmacists and tools like pharmacy warning systems can help prevent, identify and resolve DRP efficiently.
Collapse
Affiliation(s)
- J. Barceló-Vidal
- Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain,Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain,*Correspondence: J. Barceló-Vidal,
| | - D. Echeverría-Esnal
- Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain,Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain
| | - N. Carballo
- Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
| | | | - X. Fernández-Sala
- Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain,Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain
| | | | | | - S. Luque
- Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
| | - M. Fuster-Esteva
- Faculty of Medicine, Universitat Pompeu Fabra (UPF), Barcelona, Spain
| | - L. Domingo
- Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain,Department of Epidemiology and Evaluation, Barcelona, Spain
| | - M. Sala
- Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain,Department of Epidemiology and Evaluation, Barcelona, Spain
| | - X. Duran
- Statistics Deparment, Institut Hospital del Mar D'Investigacions Mèdiques (IMIM), Barcelona, Spain
| | - S. Grau
- Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain,Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain,Faculty of Medicine, Universitat Pompeu Fabra (UPF), Barcelona, Spain
| | - O. Ferrández
- Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain,Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain
| |
Collapse
|
8
|
Cybulski T, Klug Z, Nelson R, Sala M, Diaz E, Lu Z, Misharin A, Jain M. 427 Persistence of cell type–specific transcriptomic changes in the nasal epithelium of people with cystic fibrosis receiving cystic fibrosis transmembrane conductance regulator modulators. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)01117-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
9
|
Ciceri P, Bono V, Magagnoli L, Sala M, d’Arminio Monforte A, Galassi A, Barassi A, Marchetti G, Cozzolino M. Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease. Toxins (Basel) 2022; 14:toxins14100673. [PMID: 36287942 PMCID: PMC9611576 DOI: 10.3390/toxins14100673] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Revised: 09/21/2022] [Accepted: 09/26/2022] [Indexed: 11/16/2022] Open
Abstract
Chronic kidney disease (CKD) patients are more susceptible to infections compared to the general population. SARS-CoV-2 virus pathology is characterized by a cytokine storm responsible for the systemic inflammation typical of the COVID-19 disease. Since CKD patients have a reduced renal clearance, we decided to investigate whether they accumulate harmful mediators during the COVID-19 disease. We conducted a retrospective study on 77 COVID-19 hospitalized subjects in the acute phase of the illness. Thirteen different cytokines were assessed in plasma collected upon hospitalization. The patients were divided into three groups according to their estimated glomerular filtration rate, eGFR < 30 (n = 23), 30 < eGFR < 60 (n = 33), eGFR > 60 mL/min (n = 21). We found that Tumor Necrosis Factor α and its receptors I and II, Interleukin-7, Leukemia Inhibitory Factor, FAS receptor, Chitinase 3-like I, and the Vascular Endothelial Growth Factor showed an increased accumulation that negatively correlate with eGFR. Moreover, non-survivor patients with an impaired kidney function have significantly more elevated levels of the same mediators. In conclusion, there is a tendency in COVID-19 ESRD patients to accumulate harmful cytokines. The accumulation seems to associate with mortality outcomes and may be due to reduced clearance but also to increased biosynthesis in most severe cases.
Collapse
Affiliation(s)
- Paola Ciceri
- Department of Health Sciences, Renal Division, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy
| | - Valeria Bono
- Department of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy
| | - Lorenza Magagnoli
- Department of Health Sciences, Renal Division, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy
| | - Matteo Sala
- Department of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy
| | - Antonella d’Arminio Monforte
- Department of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy
| | - Andrea Galassi
- Department of Health Sciences, Renal Division, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy
| | - Alessandra Barassi
- Laboratory of Clinical Biochemistry, Department of Health Sciences, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy
| | - Giulia Marchetti
- Department of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy
| | - Mario Cozzolino
- Department of Health Sciences, Renal Division, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy
- Correspondence:
| |
Collapse
|
10
|
Masnou H, Aguilar A, Iborra I, Sala M, Torner M, Clos-Parals A, Ardèvol A, Giménez M, Fortuny M, Sarrias MR, Morillas RM, Domènech E. Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: a prospective study. Gastroenterología y Hepatología 2022; 46:288-296. [PMID: 36115630 DOI: 10.1016/j.gastrohep.2022.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/04/2022] [Revised: 08/24/2022] [Accepted: 09/10/2022] [Indexed: 10/14/2022]
Abstract
BACKGROUND Bacterial infections remain one of the main complications in cirrhosis and worsen patients' prognosis and quality of life. An increase in multidrug resistant microorganism (MDRM) infections among patients with cirrhosis, together with infection-related mortality rates, have been reported in recent years. Therefore, adaptation of the initial empiric antibiotic approach to different factors, particularly the local epidemiology of MDRM infections, has been recommended. We aim to describe the main features, outcomes and risk factors of MDRM infections in patients with cirrhosis. METHODS Prospective registry of all episodes of in-hospital infections occurring among cirrhotic patients admitted within a 2-year period at a single center. Clinical and microbiological data were collected at the time of infection diagnosis, and the in-hospital mortality rate of the infectious episode was registered. RESULTS A total of 139 infectious episodes were included. The disease-causing microorganism was identified in 90 episodes (65%), of which 31 (22%) were caused by MDRM. The only two factors independently associated with MDRM infections were rectal colonization by MDRM and a nosocomial or healthcare-associated source. The infection-related mortality rate was 18.7%. MDRM infection and a past history of hepatic encephalopathy were independently associated with in-hospital mortality. CONCLUSIONS Almost one fourth of bacterial infections occurring in admitted cirrhotic patients were due to MDRM. Rectal colonization was the most important risk factor for MDRM infections in decompensated cirrhosis. Screening for MDRM rectal colonization in patients admitted for decompensated cirrhosis should be assessed as a tool to improve local empiric antibiotic strategies.
Collapse
|
11
|
Jain M, Sala M, Markov N, Politanska Y, Abdala-Valencia H, Misharin A. P018 People with cystic fibrosis do not show an increased interferonresponse transcriptomic signature in nasal epithelial cells. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00351-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
12
|
Domingo L, Sala M, Miret C, Montero-Moraga JM, Lasso de la Vega C, Comas M, Castells X. Perceptions from nurses, surgeons, and anesthetists about the use and benefits of the surgical checklist in a teaching hospital. J Healthc Qual Res 2022; 37:52-59. [PMID: 34344625 DOI: 10.1016/j.jhqr.2021.06.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2021] [Revised: 05/31/2021] [Accepted: 06/14/2021] [Indexed: 06/13/2023]
Abstract
OBJECTIVE To assess attitudes and perceptions from nursing staff, surgeons and anesthetists about compliance, utility, and impact on patient's safety of the surgical checklist in a teaching hospital. We also aimed to identify improvement opportunities for strengthening the usefulness of the checklist in the operating theater. METHODS We carried out a questionnaire-based an observational cross-sectional study. A questionnaire was distributed to operating room staff, including nursing staff, surgeons, and anesthetists. In addition to the information about surgical checklist, We also collected information regarding years of experience in the operating theater. Fisher's exact was used to compare proportions in each statement. Group discussion meetings with key professionals were held to jointly assess the results, propose improvement actions, and evaluate their feasibility. RESULTS The overall response rate was 36.2% (131/362). Nursing staff was perceived as the most supportive group in the use of surgical checklist. A 64.3% of surgeons considered that using the checklist prevented adverse events vs 84.2% and 85.7% among anesthetists and nurses, respectively; p=0.028. Junior staff showed a supportive attitude toward the use of surgical checklist, considering it as a tool that gives them confidence. We ended up with a list of improvement actions aiming at strengthening the surgical checklist reliability and compliance. CONCLUSIONS The perception of the surgical checklist usefulness as a tool to prevent adverse events was moderate among surgeons, but well appreciated by junior staff. Nursing staff were especially critical regarding compliance and support by other professionals. To reinforce the usefulness perception of the surgical checklist it is needed to increase the involvement of all professionals, especially senior staff and surgical leaders.
Collapse
Affiliation(s)
- L Domingo
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain; Research Network on Health Services in Chronic Diseases (REDISSEC), Av. de Monforte de Lemos, 5, 28029 Madrid, Spain.
| | - M Sala
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain; Research Network on Health Services in Chronic Diseases (REDISSEC), Av. de Monforte de Lemos, 5, 28029 Madrid, Spain
| | - C Miret
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain
| | - J M Montero-Moraga
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain
| | - C Lasso de la Vega
- Methodology, Quality and Nursing Research Department, Consorci Parc de Salut MAR de Barcelona, Barcelona, Spain
| | - M Comas
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain; Research Network on Health Services in Chronic Diseases (REDISSEC), Av. de Monforte de Lemos, 5, 28029 Madrid, Spain
| | - X Castells
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain; Research Network on Health Services in Chronic Diseases (REDISSEC), Av. de Monforte de Lemos, 5, 28029 Madrid, Spain
| |
Collapse
|
13
|
D’Arminio Monforte A, Tavelli A, Bai F, Tomasoni D, Falcinella C, Castoldi R, Barbanotti D, Mulè G, Allegrini M, Suardi E, Tesoro D, Tagliaferri G, Mondatore D, Augello M, Cona A, Beringheli T, Gemignani N, Sala M, Varisco B, Molà F, Pettenuzzo S, Biasioli L, Copes A, Gazzola L, Viganò O, Tincati C, De Bona A, Bini T, Marchetti G. Declining Mortality Rate of Hospitalised Patients in the Second Wave of the COVID-19 Epidemics in Italy: Risk Factors and the Age-Specific Patterns. Life (Basel) 2021; 11:979. [PMID: 34575128 PMCID: PMC8464683 DOI: 10.3390/life11090979] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2021] [Revised: 09/10/2021] [Accepted: 09/13/2021] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Mortality rate from COVID-19 in Italy is among the world's highest. We aimed to ascertain whether there was any reduction of in-hospital mortality in patients hospitalised for COVID-19 in the second-wave period (October 2020-January 2021) compared to the first one (February-May 2020); further, we verified whether there were clusters of hospitalised patients who particularly benefitted from reduced mortality rate. METHODS Data collected related to in-patients' demographics, clinical, laboratory, therapies and outcome. Primary end-point was time to in-hospital death. Factors associated were evaluated by uni- and multivariable analyses. A flow diagram was created to determine the rate of in-hospital death according to individual and disease characteristics. RESULTS A total of 1561 patients were included. The 14-day cumulative incidence of in-hospital death by competing risk regression was of 24.8% (95% CI: 21.3-28.5) and 15.9% (95% CI: 13.7-18.2) in the first and second wave. We observed that the highest relative reduction of death from first to second wave (more than 47%) occurred mainly in the clusters of patients younger than 70 years. CONCLUSIONS Progress in care and supporting therapies did affect population over 70 years to a lesser extent. Preventive and vaccination campaigns should focus on individuals whose risk of death from COVID-19 remains high.
Collapse
Affiliation(s)
- Antonella D’Arminio Monforte
- Institute of Infectious Diseases, Department of Health Science, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy; (A.T.); (F.B.); (D.T.); (C.F.); (R.C.); (D.B.); (G.M.); (M.A.); (E.S.); (D.T.); (G.T.); (D.M.); (M.A.); (A.C.); (T.B.); (N.G.); (M.S.); (B.V.); (F.M.); (S.P.); (L.B.); (A.C.); (L.G.); (O.V.); (C.T.); (A.D.B.); (T.B.); (G.M.)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Vezzoli E, Calì C, De Roo M, Ponzoni L, Sogne E, Gagnon N, Francolini M, Braida D, Sala M, Muller D, Falqui A, Magistretti PJ. Ultrastructural Evidence for a Role of Astrocytes and Glycogen-Derived Lactate in Learning-Dependent Synaptic Stabilization. Cereb Cortex 2021; 30:2114-2127. [PMID: 31807747 PMCID: PMC7174989 DOI: 10.1093/cercor/bhz226] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2019] [Revised: 08/17/2019] [Accepted: 08/28/2019] [Indexed: 12/12/2022] Open
Abstract
Long-term memory formation (LTM) is a process accompanied by energy-demanding structural changes at synapses and increased spine density. Concomitant increases in both spine volume and postsynaptic density (PSD) surface area have been suggested but never quantified in vivo by clear-cut experimental evidence. Using novel object recognition in mice as a learning task followed by 3D electron microscopy analysis, we demonstrate that LTM induced all aforementioned synaptic changes, together with an increase in the size of astrocytic glycogen granules, which are a source of lactate for neurons. The selective inhibition of glycogen metabolism in astrocytes impaired learning, affecting all the related synaptic changes. Intrahippocampal administration of l-lactate rescued the behavioral phenotype, along with spine density within 24 hours. Spine dynamics in hippocampal organotypic slices undergoing theta burst-induced long-term potentiation was similarly affected by inhibition of glycogen metabolism and rescued by l-lactate. These results suggest that learning primes astrocytic energy stores and signaling to sustain synaptic plasticity via l-lactate.
Collapse
Affiliation(s)
- E Vezzoli
- Biological and Environmental Sciences and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), 23955-6900 Thuwal, Saudi Arabia.,Dipartimento di Bioscienze, Università degli Studi di Milano, 20133 Milano, Italy.,Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, 20133 Milano, Italy
| | - C Calì
- Biological and Environmental Sciences and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), 23955-6900 Thuwal, Saudi Arabia
| | - M De Roo
- Department of Basic Neuroscience, University of Geneva Medical School, 1206 Geneva, Switzerland
| | - L Ponzoni
- Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, 20133 Milano, Italy
| | - E Sogne
- Biological and Environmental Sciences and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), 23955-6900 Thuwal, Saudi Arabia
| | - N Gagnon
- Biological and Environmental Sciences and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), 23955-6900 Thuwal, Saudi Arabia
| | - M Francolini
- Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, 20133 Milano, Italy
| | - D Braida
- Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, 20133 Milano, Italy
| | - M Sala
- CNR, Institute of Neuroscience, 20129 Milano, Italy
| | - D Muller
- Department of Basic Neuroscience, University of Geneva Medical School, 1206 Geneva, Switzerland
| | - A Falqui
- Biological and Environmental Sciences and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), 23955-6900 Thuwal, Saudi Arabia
| | - P J Magistretti
- Biological and Environmental Sciences and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), 23955-6900 Thuwal, Saudi Arabia
| |
Collapse
|
15
|
van Leeuwen CAT, Sala M, Schipper IB, Krijnen P, Zijta F, Hoogendoorn JM. The additional value of weight-bearing and gravity stress ankle radiographs in determining stability of isolated type B ankle fractures. Eur J Trauma Emerg Surg 2021; 48:2287-2296. [PMID: 34331545 DOI: 10.1007/s00068-021-01757-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Accepted: 07/18/2021] [Indexed: 11/25/2022]
Abstract
GOAL The aim of this study is to investigate whether weight-bearing and gravity stress radiographs have additional value in predicting concomitant deep deltoid ligamentous (DDL) injury in case of isolated Weber type B fibular fractures. This may help to make the clinically relevant distinction between unstable fractures and fractures that can be treated conservatively. METHODS In this prospective cohort study, 90 patients with an isolated type B ankle fracture, without a medial or posterior fracture, and a medial clear space (MCS) < 6 mm on the regular mortise (RM) view were included. In all patients, an additional gravity stress (GS) view and an MRI scan were performed. Furthermore, in 51 patients, an additional weight-bearing (WB) radiograph was performed. The MCS and superior clear space (SCS) measurements of these radiographs were compared with MRI findings to measure sensitivity and specificity in excluding deep deltoid ligament (DDL) rupture. RESULTS The mean MCS on the RM view was 3.32 mm (1.73-5.93) compared to 4.75 mm (2.33-10.40) on the GS view and 3.18 mm (1.93-6.9) on the WB radiograph. MRI showed a high-grade or complete deltoid ligament tear in 25 (28%) patients. Using an MCS cut-off value of ≥ SCS + 2 mm, the RM view showed 0% sensitivity and 97% specificity in diagnosing a DDL rupture. Both the GS view (with MCS ≥ SCS + 3 mm as cut-off value) and the WB radiograph (with cut-off value MCS ≥ SCS + 2 mm) showed 6% sensitivity and 100% specificity. CONCLUSION The gravity stress and weight-bearing radiograph can accurately exclude DDL injury. They might have extra value in addition to the conventional mortise view in assessing the stability of isolated type B ankle fractures. This helps in deciding whether patients should be selected for operative or safe conservative treatment.
Collapse
Affiliation(s)
- C A T van Leeuwen
- Department of Trauma Surgery, Haaglanden Medical Center, Hague, The Netherlands.
| | - M Sala
- Department of Radiology, Haaglanden Medical Center, Hague, The Netherlands
| | - I B Schipper
- Department of Trauma Surgery, Leiden University Medical Center, Leiden, The Netherlands
| | - P Krijnen
- Department of Trauma Surgery, Leiden University Medical Center, Leiden, The Netherlands
| | - F Zijta
- Department of Radiology, Haaglanden Medical Center, Hague, The Netherlands
| | - J M Hoogendoorn
- Department of Trauma Surgery, Haaglanden Medical Center, Hague, The Netherlands
| |
Collapse
|
16
|
Jansana A, Comas M, Domingo L, Prados-Torres A, Gimeno-Miguel A, Poblador-Plou B, Castells X, Sala M. Multimorbidity patterns among long-term breast cancer survivors: a Spanish population-based study. Breast 2021. [DOI: 10.1016/s0960-9776(21)00241-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
17
|
Tomic R, Perottino G, Collins M, Oboye A, Amblavanan A, Sala M. Frailty Measurements are Poor Predictor of Lung Transplantation Outcomes. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
18
|
Franco F, Carcereny E, Rodríguez-Abreu D, Castro RL, Cobo M, Guirado M, Massuti B, Granados AO, Mosquera J, Juan O, Blasco A, Del Barco E, Caro RB, Bosch-Barrera J, Gonzalez-Larriba J, Sala M, Pérez JT, Oramas J, Estival A, Provencio M. P52.10 Profile of Comorbidities and Cancer History in Patients with mNSCLC in the Spanish Population (Thoracic Tumors Registry). J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
19
|
Calvo V, Ruano-Ravina A, Carcereny E, Moran T, Rodríguez-Abreu D, López-Castro R, Cuadrado-Albite E, Guirado M, Gomez-Gonzalez L, Massuti B, Granados AO, Blasco A, Dols MC, Mosquera J, Hernandez-Martinez A, Trigo J, Juan O, De La Rosa CA, Gómez MD, Sala M, Oramas J, Ojea CG, Cerezo S, Provencio M. P52.05 Lung Cancer Symptoms at Diagnosis: Data from the Thoracic Tumors Registry (TTR Study). J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
20
|
Longaretti A, Forastieri C, Toffolo E, Caffino L, Locarno A, Misevičiūtė I, Marchesi E, Battistin M, Ponzoni L, Madaschi L, Cambria C, Bonasoni MP, Sala M, Perrone D, Fumagalli F, Bassani S, Antonucci F, Tonini R, Francolini M, Battaglioli E, Rusconi F. LSD1 is an environmental stress-sensitive negative modulator of the glutamatergic synapse. Neurobiol Stress 2020; 13:100280. [PMID: 33457471 PMCID: PMC7794663 DOI: 10.1016/j.ynstr.2020.100280] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2020] [Revised: 11/19/2020] [Accepted: 11/22/2020] [Indexed: 12/22/2022] Open
Abstract
Along with neuronal mechanisms devoted to memory consolidation –including long term potentiation of synaptic strength as prominent electrophysiological correlate, and inherent dendritic spines stabilization as structural counterpart– negative control of memory formation and synaptic plasticity has been described at the molecular and behavioral level. Within this work, we report a role for the epigenetic corepressor Lysine Specific Demethylase 1 (LSD1) as a negative neuroplastic factor whose stress-enhanced activity may participate in coping with adverse experiences. Constitutively increasing LSD1 activity via knocking out its dominant negative splicing isoform neuroLSD1 (neuroLSD1KO mice), we observed extensive structural, functional and behavioral signs of excitatory decay, including disrupted memory consolidation. A similar LSD1 increase, obtained with acute antisense oligonucleotide-mediated neuroLSD1 splicing knock down in primary neuronal cultures, dampens spontaneous glutamatergic transmission, reducing mEPSCs. Remarkably, LSD1 physiological increase occurs in response to psychosocial stress-induced glutamatergic signaling. Since this mechanism entails neuroLSD1 splicing downregulation, we conclude that LSD1/neuroLSD1 ratio modulation in the hippocampus is instrumental to a negative homeostatic feedback, restraining glutamatergic neuroplasticity in response to glutamate. The active process of forgetting provides memories with salience. With our work, we propose that softening memory traces of adversities could further represent a stress-coping process in which LSD1/neuroLSD1 ratio modulation may help preserving healthy emotional references.
Collapse
Affiliation(s)
- A Longaretti
- Dept. of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via F.lli Cervi, 93, Segrate (MI), Italy
| | - C Forastieri
- Dept. of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via F.lli Cervi, 93, Segrate (MI), Italy
| | - E Toffolo
- Dept. of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via F.lli Cervi, 93, Segrate (MI), Italy
| | - L Caffino
- Dept. of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Via Balzaretti, 9, Milano, Italy
| | - A Locarno
- Neuromodulation of Cortical and Subcortical Circuits Laboratory, Istituto Italiano di Tecnologia, Via Morengo, 30, Genova, 16163, Italy
| | - I Misevičiūtė
- Neuromodulation of Cortical and Subcortical Circuits Laboratory, Istituto Italiano di Tecnologia, Via Morengo, 30, Genova, 16163, Italy
| | - E Marchesi
- Dept. of Chemical and Pharmaceutical Sciences, Università di Ferrara, Via Borsari, 46, Ferrara, Italy
| | - M Battistin
- Dept. of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via F.lli Cervi, 93, Segrate (MI), Italy
| | - L Ponzoni
- Institute of Neuroscience, Consiglio Nazionale Delle Ricerche (CNR), Via Vanvitelli, 32, Milan, Italy
| | - L Madaschi
- UNITECH NO LIMITS, Università Degli Studi di Milano, Via Celoria, 26, Milan, Italy
| | - C Cambria
- Dept. of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via F.lli Cervi, 93, Segrate (MI), Italy
| | - M P Bonasoni
- ASMN Santa Maria Nuova Via Risorgimento, 80 Reggio Emilia, Italy
| | - M Sala
- Institute of Neuroscience, Consiglio Nazionale Delle Ricerche (CNR), Via Vanvitelli, 32, Milan, Italy
| | - D Perrone
- Dept. of Chemical and Pharmaceutical Sciences, Università di Ferrara, Via Borsari, 46, Ferrara, Italy
| | - F Fumagalli
- Dept. of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Via Balzaretti, 9, Milano, Italy
| | - S Bassani
- Institute of Neuroscience, Consiglio Nazionale Delle Ricerche (CNR), Via Vanvitelli, 32, Milan, Italy
| | - F Antonucci
- Dept. of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via F.lli Cervi, 93, Segrate (MI), Italy
| | - R Tonini
- Neuromodulation of Cortical and Subcortical Circuits Laboratory, Istituto Italiano di Tecnologia, Via Morengo, 30, Genova, 16163, Italy
| | - M Francolini
- Dept. of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via F.lli Cervi, 93, Segrate (MI), Italy
| | - E Battaglioli
- Dept. of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via F.lli Cervi, 93, Segrate (MI), Italy
| | - F Rusconi
- Dept. of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via F.lli Cervi, 93, Segrate (MI), Italy
| |
Collapse
|
21
|
Louro J, Román M, Posso M, Vidal C, Prieto M, Saladié F, Baré M, Sánchez M, Quintana M, Bargalló X, Ferrer J, Peñalva L, Sala M, Castells X. Differences in breast cancer risk after a benign breast disease according to the screening type. Eur J Cancer 2020. [DOI: 10.1016/s0959-8049(20)30552-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
22
|
Jansana A, Cura MD, Sanz T, Poblador B, Padilla M, Domingo L, Merce C, Prados-Torres A, Ibañez B, Tamayo I, Gimeno A, Redondo M, Castells X, Sala M. Evaluation of the use of primary and hospital care in long-term breast cancer survivors: A longitudinal study based on real-world data. Eur J Cancer 2020. [DOI: 10.1016/s0959-8049(20)30777-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
23
|
Sala M, Uccello A, Dellasega D, Pedroni M, Vassallo E, Passoni M. Exposures of bulk W and nanostructured W coatings to medium flux D plasmas. Nuclear Materials and Energy 2020. [DOI: 10.1016/j.nme.2020.100779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
24
|
Cellina M, Orsi M, Bombaci F, Sala M, Marino P, Oliva G. Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab. Diagn Interv Imaging 2020; 101:323-324. [PMID: 32278585 PMCID: PMC7270926 DOI: 10.1016/j.diii.2020.03.010] [Citation(s) in RCA: 81] [Impact Index Per Article: 20.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2020] [Accepted: 03/26/2020] [Indexed: 01/12/2023]
Affiliation(s)
- M Cellina
- Department of Radiology, Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco, 20121 Milan, Italy.
| | - M Orsi
- Department of Radiology, Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco, 20121 Milan, Italy
| | - F Bombaci
- Department of Radiology, Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco, 20121 Milan, Italy
| | - M Sala
- Emergency Department, Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco, 20121 Milan, Italy
| | - P Marino
- Emergency Department, Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco, 20121 Milan, Italy
| | - G Oliva
- Department of Radiology, Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco, 20121 Milan, Italy
| |
Collapse
|
25
|
Tomic R, O'Boye A, Galyayeva I, Maturlak M, Wright J, Pelko D, Pesce L, Sala M. Characteristics of Frailty in Lung Transplant Candidates. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
26
|
Barlozzari G, Sala M, Iacoponi F, Volpi C, Polinori N, Rombolà P, Vairo F, Macrì G, Scarpulla M. Cross-sectional serosurvey of Coxiella burnetii in healthy cattle and sheep from extensive grazing system in central Italy. Epidemiol Infect 2020; 148:e9. [PMID: 31957632 PMCID: PMC7019129 DOI: 10.1017/s0950268819002115] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2019] [Revised: 11/22/2019] [Accepted: 11/25/2019] [Indexed: 11/13/2022] Open
Abstract
A cross-sectional survey was carried out to estimate the seroprevalence of Coxiella burnetii in extensively grazed cattle and sheep from central Italy and to identify the related risk factors. Data on notified human Q fever cases in the area were also collected and described. A two-stage cluster sampling was performed. A total of 5083 animals (2210 cattle; 2873 sheep) belonging to 186 farms (92 herds; 94 flocks) were tested for the presence of antibodies against C. burnetii using a commercial enzyme-linked immunosorbent assay kit. The prevalence at the animal-level resulted three times higher in sheep compared to cattle (37.8% vs. 12.0%; χ2 = 270.10, P < 0.001). The prevalence at the herd-level was also higher in sheep than in cattle (87.2% vs. 68.5%; χ2 = 9.52, P < 0.01). The multivariate analysis showed a higher risk of seropositivity for cattle aged 67-107 months (OR 2.79, 95% CI 1.86-4.18), cattle >107 months of age (OR 2.07, 95% CI 1.36-3.14) and mixed breed cattle (OR 1.74, 95% CI 1.11-2.72). A herd size >92 animals was recognized as herd-level risk factor in cattle (OR 6.88, 95% CI 1.67-28.37). The risk of being seropositive was double in sheep belonging to flocks >600 animals (odds ratio (OR) 2.04, 95% CI 1.63-2.56). Sheep were confirmed to be the most exposed species. Nevertheless, the prevalence observed in cattle also suggests the potential involvement of this species in the circulation of the pathogen in the area. Seven confirmed human Q fever cases were reported. In five out of seven cases there was at least one exposed herd within a 5 km buffer. Even though the source of the infection was not identified, the possibility of C. burnetii circulating in the livestock and human population in the study area cannot be overlooked. The integration between veterinary and human surveillance will be crucial to understand the spread of this zoonosis and to support the adoption of appropriate control measures.
Collapse
Affiliation(s)
- G. Barlozzari
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Rome, Italy
| | - M. Sala
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Rome, Italy
| | - F. Iacoponi
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Rome, Italy
| | - C. Volpi
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Rome, Italy
| | - N. Polinori
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Rome, Italy
| | - P. Rombolà
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Rome, Italy
| | - F. Vairo
- Regional Service for Surveillance and Control of Infectious Diseases (SERESMI), National Institute for Infectious Diseases “Lazzaro Spallanzani” IRCCS, Rome, Italy
| | - G. Macrì
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Rome, Italy
| | - M. Scarpulla
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Rome, Italy
| |
Collapse
|
27
|
De San Vicente B, Pikabea F, Simon M, Dominguez N, Galve E, Sala M, Hoyos M, Nuño M, Del Prado P. INTERVENTIONS TO IMPROVE SATISFACTION AFTER A GERIATRIC ASSESSMENT IN PATIENTS WITH LUNG CANCER. J Geriatr Oncol 2019. [DOI: 10.1016/s1879-4068(19)31213-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
28
|
Pedrinaci IZ, Perez D, Rivas-Ruiz F, Sala M, Padilla-Ruiz M, Alcaide-Garcia J, Perez-Ruiz E, Villatoro R, Navarro V, Redondo M. Influence of first treatment delay on survival among breast cancer subtypes. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz240.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
29
|
De Liberato C, Magliano A, Autorino GL, Di Domenico M, Sala M, Baldacchino F. Seasonal succession of tabanid species in equine infectious anaemia endemic areas of Italy. Med Vet Entomol 2019; 33:431-436. [PMID: 30775793 DOI: 10.1111/mve.12360] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2018] [Revised: 12/11/2018] [Accepted: 12/22/2018] [Indexed: 06/09/2023]
Abstract
Equine infectious anaemia (EIA) is a disease with an almost worldwide distribution, with several outbreaks having been reported recently in European countries. In Italy, two regions, Lazio and Abruzzo, are considered as endemic areas for this disease. In nature, the EIA virus is mechanically transmitted by biting flies such as tabanids (Diptera: Tabanidae), although few studies have investigated the epidemiological implications. In the present study, several sites characterized by different levels of EIA prevalence were sampled. In sites with high tabanid populations, a seasonal succession of tabanid species with a dual-peak corresponding to early active species (i.e. in June to July) and late active species (i.e. in August to September) was clearly observed. Moreover, a positive correlation was found between EIA prevalence and tabanid abundance and species richness, suggesting that tabanid diversity might extend the duration of the seasonal transmission period of EIA. Further observations are required to better assess how vector diversity influence EIA transmission.
Collapse
Affiliation(s)
- C De Liberato
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri", Rome, Italy
| | - A Magliano
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri", Rome, Italy
| | - G L Autorino
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri", Rome, Italy
| | - M Di Domenico
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri", Rome, Italy
| | - M Sala
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri", Rome, Italy
| | - F Baldacchino
- Direction départementale de la protection des populations du Nord, Lille, France
| |
Collapse
|
30
|
Kincl V, Sala M, Panovsky R, Kaminek M, Vasina J, Machal J. P297Assessment of left ventricular volumes and ejection fraction by ultra-low-dose thallium SPECT on CZT camera; a comparison with magnetic resonance. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez148.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- V Kincl
- St. Anne"s University Hospital, Department of Cardiovascular Diseases and ICRC, Brno, Czechia
| | - M Sala
- St. Annes University Hospital, Department of Cardiovascular Diseases, Brno, Czechia
| | - R Panovsky
- St. Anne"s University Hospital, Department of Cardiovascular Diseases and ICRC, Brno, Czechia
| | - M Kaminek
- University Hospital Olomouc, Department of Nuclear Medicine , Olomouc, Czechia
| | - J Vasina
- International Clinical Research Center, Nuclear Cardiology, Brno, Czechia
| | - J Machal
- Masaryk University, Medical Faculty, Department of Pathophysiology, Brno, Czechia
| |
Collapse
|
31
|
Lopez-Molina M, Ganduxé XT, Iribarren AM, Espinosa M, Torres S, Sala M, Fernandez C, Abadia C, Llopis M, Morales-Indiano C. Influence of K2-EDTA and K3-EDTA tubes for monocyte distribution width measurement. Clin Chim Acta 2019. [DOI: 10.1016/j.cca.2019.03.819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
32
|
Iribarren AM, Ganduxé XT, Sala M, Lopez-Molina M, Galiano L, Juan C, Sierra I, Castillo A, Qyyum K, Llopis M, Morales-Indiano C. Performance evaluation of the new Beckman Coulter DxH-900 haematology analyzer. Clin Chim Acta 2019. [DOI: 10.1016/j.cca.2019.03.899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
33
|
Pescina S, Ostacolo C, Gomez-Monterrey IM, Sala M, Bertamino A, Sonvico F, Padula C, Santi P, Bianchera A, Nicoli S. Cell penetrating peptides in ocular drug delivery: State of the art. J Control Release 2018; 284:84-102. [PMID: 29913221 DOI: 10.1016/j.jconrel.2018.06.023] [Citation(s) in RCA: 74] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2018] [Revised: 06/12/2018] [Accepted: 06/14/2018] [Indexed: 12/22/2022]
Abstract
Despite the increasing number of effective therapeutics for eye diseases, their treatment is still challenging due to the presence of effective barriers protecting eye tissues. Cell Penetrating Peptides (CPPs), synthetic and natural short amino acid sequences able to cross cellular membrane thanks to a transduction domain, have been proposed as possible enhancing strategies for ophthalmic delivery. In this review, a general description of CPPs classes, design approaches and proposed cellular uptake mechanisms will be provided to the reader as an introduction to ocular CPPs application, together with an overview of the main problems related to ocular administration. The results obtained with CPPs for the treatment of anterior and posterior segment eye diseases will be then introduced, with a focus on non-invasive or minimally invasive administration, shifting from CPPs capability to obtain intracellular delivery to their ability to cross biological barriers. The problems related to in vitro, ex vivo and in vivo models used to investigate CPPs mediated ocular delivery will be also addressed together with potential ocular toxicity issues.
Collapse
Affiliation(s)
- S Pescina
- Food and Drug Department, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy
| | - C Ostacolo
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Napoli, Italy
| | - I M Gomez-Monterrey
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Napoli, Italy
| | - M Sala
- Department of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084 Fisciano, SA, Italy
| | - A Bertamino
- Department of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084 Fisciano, SA, Italy
| | - F Sonvico
- Food and Drug Department, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy
| | - C Padula
- Food and Drug Department, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy
| | - P Santi
- Food and Drug Department, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy
| | - A Bianchera
- BiopharmanetTEC, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy
| | - S Nicoli
- Food and Drug Department, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy.
| |
Collapse
|
34
|
Abstract
The incidence of secondary malignancies following chemotherapy is progressively increasing, mostly due to prolonged survival of patients treated for primary cancer. So far, only 3 cases of solid cancer following busulphan administration have been reported. We describe the case of a patient who developed a renal cancer after 4 years of busulphan treatment for chronic myeloid leukemia. Immunosuppression rather than mutagenesis seems to be responsible for the emergence of second solid cancers in patients receiving busulphan.
Collapse
Affiliation(s)
- A Iurlo
- Istituto di Scienze Mediche, Padiglione Granelli, Università degli Studi, Milan, Italy
| | | | | | | |
Collapse
|
35
|
Sala M, Diab R, Elaissari A, Fessi H. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications. Int J Pharm 2018; 535:1-17. [DOI: 10.1016/j.ijpharm.2017.10.046] [Citation(s) in RCA: 170] [Impact Index Per Article: 28.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2017] [Revised: 10/20/2017] [Accepted: 10/25/2017] [Indexed: 12/22/2022]
|
36
|
Peris P, Filella X, Monegal A, Guañabens N, Foj L, Bonet M, Boquet D, Casado E, Cerdá D, Erra A, Gómez-Vaquero C, Martínez S, Montalá N, Pittarch C, Kanterewicz E, Sala M, Suris X, Carrasco JL. Comparison of total, free and bioavailable 25-OH vitamin D determinations to evaluate its biological activity in healthy adults: the LabOscat study. Osteoporos Int 2017; 28:2457-2464. [PMID: 28466136 DOI: 10.1007/s00198-017-4062-8] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/20/2017] [Accepted: 04/17/2017] [Indexed: 01/07/2023]
Abstract
UNLABELLED Determination of different forms of 25-OHD (total, free and bioavailable) in healthy young women does not offer additional advantages over standard 25-OHDT for evaluating vitamin D deficiency. In these subjects 25-OHDT values <15 ng/ml would be more appropriate for defining this deficiency. INTRODUCTION Determination of 25-OH vitamin D serum levels (25-OHD) constitutes the method of choice for evaluating vitamin D deficiency. However, vitamin D-binding protein (DBP) may modulate its bioavailability thereby affecting correct evaluation of 25-OHD status. We analysed the impact of the determination of 25-OHD (total, free and bioavailable) on the evaluation its biologic activity (estimated by serum PTH determination) in healthy young women. METHODS 173 premenopausal women (aged 35-45 yrs.) were included. We analysed serum values of total 25-OHD (25-OHDT), DBP, albumin, PTH and bone formation (PINP,OC) and resorption (NTx,CTx) markers. Free(25-OHDF) and bioavailable (25-OHDB) serum 25-OHD levels were estimated by DBP and albumin determinations and also directly by ELISA (25-OHDF-2). We analysed threshold PTH values for the different forms of 25-OHD and the correlations and differences according to 25-OHDT levels <20 ng/ml. RESULTS 62% of subjects had 25-OHD values <20 ng/ml and also had significantly lower 25-OHDF and 25-OHDB values, with no significant differences in bone markers and PTH values. The PTH threshold value was similar for all forms of 25-OHD (∼70 pg/ml). Women with PTH values >70 had lower 25-OHDT (15.4 ± 1.4 vs. 18.3 ± 2.7, p < 0.05) and 25OHDB values (1.7 ± 0.2 vs. 2.2 ± 0.09, p < 0.05). The different forms of 25OHD were significantly intercorrelated, with marginal correlations between PTH and 25-OHDT (r = -0.136, p = 0.082). CONCLUSIONS Determination of different forms of 25-OHD in healthy young women does not offer additional advantages over standard 25-OHDT for evaluating vitamin D deficiency. In these subjects 25-OHDT values <15 ng/ml would be more appropriate for defining this deficiency.
Collapse
Affiliation(s)
- P Peris
- Hospital Clínic de Barcelona, IDIBAPS. CIBERehd, Barcelona, Spain.
| | - X Filella
- Servicio de Bioquímica Clínica, Hospital Clinic, Barcelona, Spain
| | - A Monegal
- Hospital Clínic de Barcelona, IDIBAPS. CIBERehd, Barcelona, Spain
| | - N Guañabens
- Hospital Clínic de Barcelona, IDIBAPS. CIBERehd, Barcelona, Spain
| | - L Foj
- Servicio de Bioquímica Clínica, Hospital Clinic, Barcelona, Spain
| | - M Bonet
- Hospital de l'Alt Penedés, Barcelona, Spain
| | - D Boquet
- Hospital Arnau de Vilanova, Lleida, Spain
| | - E Casado
- Instituto Universitario Parc Taulí, Barcelona, Spain
| | - D Cerdá
- Hospital Moisés Broggi, Barcelona, Spain
| | - A Erra
- Hospital Universitari de Bellvitge, Barcelona, Spain.
| | | | - S Martínez
- Hospital Mútua de Terrassa, Madrid, Spain
| | - N Montalá
- Hospital Sta María, Barcelona, Spain
| | | | | | - M Sala
- Hospital de Figueres, Barcelona, Spain
| | - X Suris
- Hospital de Ganollers, Catalonia, Spain
| | - J L Carrasco
- Departament de Fonaments Clínics, Universitat de Barcelona, Barcelona, Spain
| | | |
Collapse
|
37
|
Dolera M, Malfassi L, Bianchi C, Carrara N, Finesso S, Marcarini S, Mazza G, Pavesi S, Sala M, Urso G. Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas. Vet Comp Oncol 2017. [DOI: 10.1111/vco.12316] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- M. Dolera
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
| | - L. Malfassi
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
| | - C. Bianchi
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
| | - N. Carrara
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
| | - S. Finesso
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
| | - S. Marcarini
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
| | - G. Mazza
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
| | - S. Pavesi
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
| | - M. Sala
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
| | - G. Urso
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo Italy
- Azienda Socio Sanitaria Territoriale di Lodi; Lodi Italy
| |
Collapse
|
38
|
Sala M, Locher F, Bonvallet M, Agusti G, Elaissari A, Fessi H. Diclofenac Loaded Lipid Nanovesicles Prepared by Double Solvent Displacement for Skin Drug Delivery. Pharm Res 2017. [PMID: 28631206 DOI: 10.1007/s11095-017-2201-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
PURPOSE Herein, we detail a promising strategy of nanovesicle preparation based on control of phospholipid self-assembly: the Double Solvent Displacement. A systematic study was conducted and diclofenac as drug model encapsulated. In vitro skin studies were carried out to identify better formulation for dermal/transdermal delivery. METHODS This method consists in two solvent displacements. The first one, made in a free water environment, has allowed triggering a phospholipid pre-organization. The second one, based on the diffusion into an aqueous phase has led to liposome formation. RESULTS Homogeneous liposomes were obtained with a size close to 100 nm and a negative zeta potential around -40 mV. After incorporation of acid diclofenac, we obtained nanoliposomes with a size between 101 ± 45 and 133 ± 66 nm, a zeta potential between 34 ± 2 and 49 ± 3 mV, and the encapsulation efficiency (EE%) was between 58 ± 3 and 87 ± 5%. In vitro permeation studies showed that formulation with higher EE% dispayed the higher transdermal passage (18,4% of the applied dose) especially targeting dermis and beyond. CONCLUSIONS Our results suggest that our diclofenac loaded lipid vesicles have significant potential as transdermal skin drug delivery system. Here, we produced cost effective lipid nanovesicles in a merely manner according to a process easily transposable to industrial scale. Graphical Abstract ᅟ.
Collapse
Affiliation(s)
- M Sala
- University of Lyon, University Claude Bernard Lyon-1, CNRS, LAGEP UMR 5007, 43 bd. du 11 Nov.1918, F-69622, Villeurbanne, France.,Hospices Civils de Lyon, Pharmacie Centrale, Laboratoire de Contrôle, 57, Rue Francisque Darcieux, 69563, Saint Genis Laval, France.,School of pharmacy, ISPB (Institut des sciences pharmaceutiques et biologiques) of Lyon, 8 avenue Rockefeller, 69373, LYON CEDEX 08, France
| | - F Locher
- Hospices Civils de Lyon, Pharmacie Centrale, Laboratoire de Contrôle, 57, Rue Francisque Darcieux, 69563, Saint Genis Laval, France.,School of pharmacy, ISPB (Institut des sciences pharmaceutiques et biologiques) of Lyon, 8 avenue Rockefeller, 69373, LYON CEDEX 08, France
| | - M Bonvallet
- Hospices Civils de Lyon, Pharmacie Centrale, Laboratoire de Contrôle, 57, Rue Francisque Darcieux, 69563, Saint Genis Laval, France
| | - G Agusti
- University of Lyon, University Claude Bernard Lyon-1, CNRS, LAGEP UMR 5007, 43 bd. du 11 Nov.1918, F-69622, Villeurbanne, France
| | - A Elaissari
- University of Lyon, University Claude Bernard Lyon-1, CNRS, LAGEP UMR 5007, 43 bd. du 11 Nov.1918, F-69622, Villeurbanne, France.
| | - H Fessi
- University of Lyon, University Claude Bernard Lyon-1, CNRS, LAGEP UMR 5007, 43 bd. du 11 Nov.1918, F-69622, Villeurbanne, France.,School of pharmacy, ISPB (Institut des sciences pharmaceutiques et biologiques) of Lyon, 8 avenue Rockefeller, 69373, LYON CEDEX 08, France
| |
Collapse
|
39
|
Román M, Quintana MJ, Ferrer J, Sala M, Castells X. Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening. Br J Cancer 2017; 116:1480-1485. [PMID: 28427083 PMCID: PMC5520087 DOI: 10.1038/bjc.2017.107] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2016] [Revised: 03/23/2017] [Accepted: 03/27/2017] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Our aim was to assess the cumulative risk of false-positive screening results, screen-detected cancer, and interval breast cancer in mammography screening among women with and without a previous benign breast disease and a family history of breast cancer. METHODS The cohort included 42 928 women first screened at the age of 50-51 years at three areas of the Spanish Screening Programme (Girona, and two areas in Barcelona) between 1996 and 2011, and followed up until December 2012. We used discrete-time survival models to estimate the cumulative risk of each screening outcome over 10 biennial screening exams. RESULTS The cumulative risk of false-positive results, screen-detected breast cancer, and interval cancer was 36.6, 5.3, and 1.4 for women with a previous benign breast disease, 24.1, 6.8, and 1.6% for women with a family history of breast cancer, 37.9, 9.0, and 3.2%; for women with both a previous benign breast disease and a family history, and 23.1, 3.2, and 0.9% for women without either of these antecedents, respectively. CONCLUSIONS Women with a benign breast disease or a family history of breast cancer had an increased cumulative risk of favourable and unfavourable screening outcomes than women without these characteristics. A family history of breast cancer did not increase the cumulative risk of false-positive results. Identifying different risk profiles among screening participants provides useful information to stratify women according to their individualised risk when personalised screening strategies are discussed.
Collapse
Affiliation(s)
- M Román
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim 25-29, Barcelona 08003, Spain
- Health Services Research on Chronic Patients Network (REDISSEC), Barrio Labeaga s/n, Bizkaia 48960, Spain
| | - M J Quintana
- Department of Epidemiology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí 89, Barcelona 08026, Spain
| | - J Ferrer
- Department of Radiology, Hospital de Santa Caterina, Dr Castany s/n, Girona 17190, Spain
| | - M Sala
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim 25-29, Barcelona 08003, Spain
- Health Services Research on Chronic Patients Network (REDISSEC), Barrio Labeaga s/n, Bizkaia 48960, Spain
| | - X Castells
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim 25-29, Barcelona 08003, Spain
- Health Services Research on Chronic Patients Network (REDISSEC), Barrio Labeaga s/n, Bizkaia 48960, Spain
| |
Collapse
|
40
|
Vicidomini C, Ponzoni L, Lim D, Schmeisser MJ, Reim D, Morello N, Orellana D, Tozzi A, Durante V, Scalmani P, Mantegazza M, Genazzani AA, Giustetto M, Sala M, Calabresi P, Boeckers TM, Sala C, Verpelli C. Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice. Mol Psychiatry 2017; 22:784. [PMID: 27113996 DOI: 10.1038/mp.2016.70] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
41
|
Caminiti A, Pelone F, LaTorre G, De Giusti M, Saulle R, Mannocci A, Sala M, Della Marta U, Scaramozzino P. Control and eradication of tuberculosis in cattle: a systematic review of economic evidence. Vet Rec 2017; 179:70-5. [PMID: 27422918 DOI: 10.1136/vr.103616] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Bovine tuberculosis (TB) is a disease of zoonotic importance for which control and eradication programmes have been carried out in many countries for decades. While the impact of these programmes on public health is still uncertain, the impact on trade is significant because of movement restrictions for animals, costs of testing and culling. The objective of this systematic review was to provide a contribution to the general debate over costs against benefits for the control and eradication of bovine TB in cattle. The search strategy was performed on four electronic databases following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The selection process, data abstraction and quality appraisal were carried out according to the Cochrane Collaboration guidelines. The search identified 66 articles out of which eight fulfilled the inclusion criteria. The evidence gathered in this review by combining the conclusions of the most methodologically sound articles supports the idea that, when multiple cost and benefit components are taken into account, efforts to control or eradicate bovine TB may be effective in reducing disease prevalence, economically viable and worth doing.
Collapse
Affiliation(s)
- A Caminiti
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, via A. Bianchi, 9, 25124 Brescia, Italy
| | - F Pelone
- Sapienza University of Rome, Piazzale A. Moro, 5, 00185 Rome, Italy
| | - G LaTorre
- Sapienza University of Rome, Piazzale A. Moro, 5, 00185 Rome, Italy
| | - M De Giusti
- Sapienza University of Rome, Piazzale A. Moro, 5, 00185 Rome, Italy
| | - R Saulle
- Sapienza University of Rome, Piazzale A. Moro, 5, 00185 Rome, Italy
| | - A Mannocci
- Sapienza University of Rome, Piazzale A. Moro, 5, 00185 Rome, Italy
| | - M Sala
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, via Appia Nuova, 1411, 00178 Rome, Italy
| | - U Della Marta
- Area Sanità Veterinaria della Direzione Politiche della Prevenzione e Sicurezza sul lavoro, Regione Lazio, via R. Raimondi Garibaldi, 7, 00145 Rome, Italy Dr Caminiti is also at Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, via Appia Nuova, 1411, 00178 Rome, Italy
| | - P Scaramozzino
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, via Appia Nuova, 1411, 00178 Rome, Italy
| |
Collapse
|
42
|
Bochicchio S, Sala M, Spensiero A, Scala MC, Gomez-Monterrey IM, Lamberti G, Barba AA. On the design of tailored liposomes for KRX29 peptide delivery. NEW J CHEM 2017. [DOI: 10.1039/c7nj03115g] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The high interest in therapeutic peptides, due to the specificity of their mechanisms of action, has stimulated the research of new delivery strategies to overcome bioavailability problems concerning the use of peptides in their naked form. In this study liposomal suitable delivery system was designed and produced.
Collapse
Affiliation(s)
- S. Bochicchio
- Dipartimento di Farmacia
- University of Salerno
- Fisciano (SA)
- Italy
| | - M. Sala
- Dipartimento di Farmacia
- University of Salerno
- Fisciano (SA)
- Italy
| | - A. Spensiero
- Dipartimento di Farmacia
- University of Salerno
- Fisciano (SA)
- Italy
| | - M. C. Scala
- Dipartimento di Farmacia
- University of Salerno
- Fisciano (SA)
- Italy
| | | | - G. Lamberti
- Dipartimento di Ingegneria Industriale
- University of Salerno
- Italy
| | - A. A. Barba
- Dipartimento di Farmacia
- University of Salerno
- Fisciano (SA)
- Italy
| |
Collapse
|
43
|
Abstract
We investigate the dependence of Poincaré recurrence-time statistics on the choice of recurrence set by sampling the dynamics of two- and four-dimensional Hamiltonian maps. We derive a method that allows us to visualize the direct relation between the shape of a recurrence set and the values of its return probability distribution in arbitrary phase-space dimensions. Such a procedure, which is shown to be quite effective in the detection of tiny regions of regular motion, allows us to explain why similar recurrence sets have very different distributions and how to modify them in order to enhance their return probabilities. Applied to data, this enables us to understand the coexistence of extremely long, transient powerlike decays whose anomalous exponent depends on the chosen recurrence set.
Collapse
Affiliation(s)
- Matteo Sala
- Departamento de Física, Universidade do Estado de Santa Catarina, 89219-710 Joinville, Brazil
| | - Roberto Artuso
- Center for Nonlinear and Complex Systems and Dipartimento di Scienza ed Alta Tecnologia, Via Valleggio 11, 22100 Como, Italy.,INFN, Sezione di Milano, Via Celoria 16, 20133 Milano, Italy
| | - Cesar Manchein
- Departamento de Física, Universidade do Estado de Santa Catarina, 89219-710 Joinville, Brazil
| |
Collapse
|
44
|
Abstract
We propose new methods to numerically approximate non-attracting sets governing transiently chaotic systems. Trajectories starting in a vicinity Ω of these sets escape Ω in a finite time τ and the problem is to find initial conditions x∈Ω with increasingly large τ=τ(x). We search points x' with τ(x')>τ(x) in a search domain in Ω. Our first method considers a search domain with size that decreases exponentially in τ, with an exponent proportional to the largest Lyapunov exponent λ1. Our second method considers anisotropic search domains in the tangent unstable manifold, where each direction scales as the inverse of the corresponding expanding singular value of the Jacobian matrix of the iterated map. We show that both methods outperform the state-of-the-art Stagger-and-Step method [Sweet et al., Phys. Rev. Lett. 86, 2261 (2001)] but that only the anisotropic method achieves an efficiency independent of τ for the case of high-dimensional systems with multiple positive Lyapunov exponents. We perform simulations in a chain of coupled Hénon maps in up to 24 dimensions (12 positive Lyapunov exponents). This suggests the possibility of characterizing also non-attracting sets in spatio-temporal systems.
Collapse
Affiliation(s)
- M Sala
- Max Planck Institute for the Physics of Complex Systems, Nöthnizer Straße 38, 01187 Dresden, Germany
| | - J C Leitão
- Max Planck Institute for the Physics of Complex Systems, Nöthnizer Straße 38, 01187 Dresden, Germany
| | - E G Altmann
- Max Planck Institute for the Physics of Complex Systems, Nöthnizer Straße 38, 01187 Dresden, Germany
| |
Collapse
|
45
|
Dolera M, Malfassi L, Pavesi S, Finesso S, Sala M, Carrara N, Marcarini S, Mazza G, Bianchi C, Urso G. Volumetric-modulated arc stereotactic radiotherapy for canine adrenocortical tumours with vascular invasion. J Small Anim Pract 2016; 57:710-717. [DOI: 10.1111/jsap.12592] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2015] [Revised: 07/12/2016] [Accepted: 07/21/2016] [Indexed: 12/31/2022]
Affiliation(s)
- M. Dolera
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo 26014 Italy
| | - L. Malfassi
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo 26014 Italy
| | - S. Pavesi
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo 26014 Italy
| | - S. Finesso
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo 26014 Italy
| | - M. Sala
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo 26014 Italy
| | - N. Carrara
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo 26014 Italy
| | - S. Marcarini
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo 26014 Italy
| | - G. Mazza
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo 26014 Italy
| | - C. Bianchi
- La Cittadina Fondazione Studi e Ricerche Veterinarie; Romanengo 26014 Italy
| | - G. Urso
- Azienda Ospedaliera della provincia di Lodi (LO); Lodi 26900 Italy
| |
Collapse
|
46
|
Pedrinaci IZ, Romero A, Louro J, Banqué M, Vernet M, Serrano L, Funez R, Medina F, Perez D, Rueda A, Sala M, Redondo M. Survival impact of adjuvant chemotherapy in screening breast cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw364.63] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
47
|
Caminiti A, Pelone F, Battisti S, Gamberale F, Colafrancesco R, Sala M, La Torre G, Della Marta U, Scaramozzino P. Tuberculosis, Brucellosis and Leucosis in Cattle: A Cost Description of Eradication Programmes in the Region of Lazio, Italy. Transbound Emerg Dis 2016; 64:1493-1504. [PMID: 27390169 DOI: 10.1111/tbed.12540] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2016] [Indexed: 11/30/2022]
Abstract
The eradication of tuberculosis, brucellosis and leucosis in cattle has not yet been achieved in the entire Italian territory. The region of Lazio, Central Italy, represents an interesting case study to evaluate the evolution of costs for these eradication programmes, as in some provinces the eradication has been officially achieved, in some others the prevalence has been close to zero for years, and in still others disease outbreaks have been continuously reported. The objectives of this study were i) to describe the costs for the eradication programmes for tuberculosis, brucellosis and leucosis in cattle carried out in Lazio between 2007 and 2011, ii) to calculate the ratio between the financial contribution of the European Union (EU) for the eradication programmes and the estimated total costs and iii) to estimate the potential savings that can be made when a province gains the certification of freedom from disease. For the i) and ii) objectives, data were collected from official sources and a costing procedure was applied from the perspective of the Regional Health Service. For the iii) objective, a Bayesian AR(1) regression was used to evaluate the average percentage reduction in costs for a province that gained the certification. The total cost for the eradication programmes adjusted for inflation to 1 January 2016 was estimated at 18 919 797 euro (5th and 95th percentiles of the distribution: 18 325 050-19 552 080 euro). When a province gained the certification of freedom from disease, costs decreased on average by (median of the posterior distribution) 47.5%, 54.5% and 54.9% for the eradication programmes of tuberculosis, brucellosis and leucosis, respectively. Information on possible savings from the reduction of control costs can help policy makers operating under budget constraints to justify the use of additional resources for the final phase of eradication.
Collapse
Affiliation(s)
- A Caminiti
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Brescia, Italy.,Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, Rome, Italy
| | - F Pelone
- Università degli Studi di Roma "La Sapienza", Rome, Italy
| | - S Battisti
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, Rome, Italy
| | - F Gamberale
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, Rome, Italy
| | - R Colafrancesco
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, Rome, Italy
| | - M Sala
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, Rome, Italy
| | - G La Torre
- Università degli Studi di Roma "La Sapienza", Rome, Italy
| | - U Della Marta
- Area Sanità Veterinaria della Direzione Politiche della Prevenzione e Sicurezza sul Lavoro, Regione Lazio, Rome, Italy
| | - P Scaramozzino
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, Rome, Italy
| |
Collapse
|
48
|
Hüter O, Sala M, Neumann H, Zhang S, Studzinski H, Egorova D, Temps F. Long-lived coherence in pentafluorobenzene as a probe of ππ* – πσ* vibronic coupling. J Chem Phys 2016; 145:014302. [DOI: 10.1063/1.4954705] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- O. Hüter
- Institute of Physical Chemistry, Christian-Albrechts-University Kiel, Olshausenstr. 40, D-24098 Kiel, Germany
| | - M. Sala
- Institute of Physical Chemistry, Christian-Albrechts-University Kiel, Olshausenstr. 40, D-24098 Kiel, Germany
| | - H. Neumann
- Institute of Physical Chemistry, Christian-Albrechts-University Kiel, Olshausenstr. 40, D-24098 Kiel, Germany
| | - S. Zhang
- Institute of Physical Chemistry, Christian-Albrechts-University Kiel, Olshausenstr. 40, D-24098 Kiel, Germany
| | - H. Studzinski
- Institute of Physical Chemistry, Christian-Albrechts-University Kiel, Olshausenstr. 40, D-24098 Kiel, Germany
| | - D. Egorova
- Institute of Physical Chemistry, Christian-Albrechts-University Kiel, Olshausenstr. 40, D-24098 Kiel, Germany
| | - F. Temps
- Institute of Physical Chemistry, Christian-Albrechts-University Kiel, Olshausenstr. 40, D-24098 Kiel, Germany
| |
Collapse
|
49
|
Sala M, Elaissari A, Fessi H. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS). J Control Release 2016; 239:182-202. [PMID: 27381248 DOI: 10.1016/j.jconrel.2016.07.003] [Citation(s) in RCA: 52] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2016] [Revised: 06/30/2016] [Accepted: 07/01/2016] [Indexed: 11/26/2022]
Abstract
Psoriasis is a chronic inflammatory disease affecting mainly the skin but which can be complicated by psoriatic arthritis (PsA).This autoimmune skin disorder concerns 2-5% of the world population. To date, the physiopathology of psoriasis is not still completely elucidated but many researches are ongoing which have led for example to the discovery of the Th17/Th22 pathway. The conventional therapeutic approaches (local or systemic route) appeal to various classes of drugs with complex mechanisms of action and non-negligible side effects. Although there is no therapy capable to cure psoriasis, the current goal is to relieve symptoms as longer as possible with a good benefit/risk ratio. That is one of the principal limits of conventional antipsoriatic drugs. New formulations based on nanoencapsulation are a promising opportunity to answer to this limit by offering an optimization of the conventional antipsoriatic drug use (higher activity, lower side effects and frequency of application, etc.). Herein, we tried to put in perspective the mechanistic insights (histological and immunological views) proposed into scientific literature these last years in order to have a better comprehension of psoriasis physiopathology resulting in skin lesions and PsA. The therapeutic armamentarium and the different strategies in the management of psoriasis are discussed in greater details. To finish, the field of encapsulation in nanoparticles is broached in order to put forward recent advances in innovative skin drug delivery systems (ISDDSs) of antipsoriatic active agents for a better efficacy, safety and compliance.
Collapse
Affiliation(s)
- M Sala
- University Claude Bernard Lyon 1, Laboratoire d'Automatique et de Génie des Procédés, CNRS, UMR 5007, LAGEP-CPE-308G, 43 bd. du 11 Nov.1918, F-69622 Villeurbanne, France; Pharmacie centrale, Hospices Civils de Lyon, 57, Rue Francisque Darcieux, 69563 Saint Genis Laval, France
| | - A Elaissari
- University Claude Bernard Lyon 1, Laboratoire d'Automatique et de Génie des Procédés, CNRS, UMR 5007, LAGEP-CPE-308G, 43 bd. du 11 Nov.1918, F-69622 Villeurbanne, France
| | - H Fessi
- University Claude Bernard Lyon 1, Laboratoire d'Automatique et de Génie des Procédés, CNRS, UMR 5007, LAGEP-CPE-308G, 43 bd. du 11 Nov.1918, F-69622 Villeurbanne, France.
| |
Collapse
|
50
|
Scaglioni S, Sala M, Stival G, Giroli M, Raimondi C, Salvioni M, Radaelli G, Agostoni C, Riva E, Giovannini M. Dietary Glycemic Load and Macronutrient Intake in Healthy Italian Children. Asia Pac J Public Health 2016; 17:88-92. [PMID: 16425651 DOI: 10.1177/101053950501700205] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The objective is of this study is to examine the relationship of dietary glycemic load (GL) and overall glycemic index (OGI) with macronutrients intake, body mass index (BMI) and insulin sensitivity in healthy children. The subjects comprised of 105 healthy non-obese eight -years old children, 60 boys and 45 girls. A Food Frequency Questionnaire (FFQ) evaluating dietary habits, GL and OGI. Insulin sensitivity was evaluated by the homeostatic model assessment (HOMA). GL was positively associated with dietary total (correlation coefficient, r=0.57) and starch (r=0.67) carbohydrates, daily consumption of pasta and white bread, cooked potatoes, bakery products and cookies, and negatively with dietary fats (r=-0.52). OGI was positively associated with daily consumption of white bread and cookies, and negatively associated with soluble carbohydrates (r=-0.35), and consumption of fibres, proteins, fruit, legumes and carrots. No significant association was found of GL or OGI with BMI or insulin sensitivity. In healthy children, GL and OGI may represent a useful indicator of quality of diet. Asia Pac J Public Health 2005; 17(2): 88-92.
Collapse
Affiliation(s)
- S Scaglioni
- Department of Pediatrics, San Paolo Hospital, University of Milan, Milan, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|